⌘K

Login Start Free

Home/Filings/4/0001493152-22-019509

4//SEC Filing

Rachman Ilya M 4

Accession 0001493152-22-019509

CIK 0001873835other

View on SEC.gov Company Profile

Filed

Jul 17, 8:00 PM ET

Accepted

Jul 18, 6:09 AM ET

Size

5.2 KB

Accession

0001493152-22-019509

Insider Transaction Report

Form 4

Period: 2022-07-14

Immix Biopharma, Inc.IMMX

DirectorCEO and Chairman

Transactions

Award
Stock Options
2022-07-14+250,000→ 520,000 total
Exercise: $2.64Exp: 2032-07-14→ Common Stock (250,000 underlying)

Footnotes (1)

[F1]Options vest monthly in equal amounts over 48 months.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1

filerCIK 0001889334

Filing Metadata

Form type: 4
Filed: Jul 17, 8:00 PM ET
Accepted: Jul 18, 6:09 AM ET
Size: 5.2 KB

View on SEC.gov